Does HCV Core Antigen or Nucleic Acid Testing in Graft Donors Improve Organ Transplantation Viral Safety?

MLA

Challine, D., et al. “Does HCV Core Antigen or Nucleic Acid Testing in Graft Donors Improve Organ Transplantation Viral Safety?” Transfusion, vol. 41, Sept. 2001, p. 3S–4S. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=11257809&authtype=sso&custid=ns315887.

APA

Challine, D., Dameron, G., Laperche, L., Larderie, P., Rigot, P., Claquin, J., Dhumeaux, D., & Pawlotsky, J. (2001). Does HCV Core Antigen or Nucleic Acid Testing in Graft Donors Improve Organ Transplantation Viral Safety? Transfusion, 41, 3S–4S.

Chicago

Challine, D., G. Dameron, L. Laperche, P. Larderie, P. Rigot, J. Claquin, D. Dhumeaux, and J. Pawlotsky. 2001. “Does HCV Core Antigen or Nucleic Acid Testing in Graft Donors Improve Organ Transplantation Viral Safety?” Transfusion 41 (September): 3S–4S. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=11257809&authtype=sso&custid=ns315887.